Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ripphausen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|March 31, 2012
Virtual compound screening in drug discoveryDagmar Stumpfe, Peter Ripphausen, Jürgen Bajorath
Journal of Chemical Information and Modeling|September 10, 2011
REPROVIS-DB: a benchmark system for ligand-based virtual screening derived from reproducible prospective applicationsPeter Ripphausen, Anne Mai Wassermann, Jürgen Bajorath
Drug Discovery Today|February 26, 2011
State-of-the-art in ligand-based virtual screeningPeter Ripphausen, Britta Nisius, Jürgen Bajorath
Future Medicinal Chemistry|March 31, 2012
Analysis of structure-based virtual screening studies and characterization of identified active compoundsPeter Ripphausen, Dagmar Stumpfe, Jürgen Bajorath
Journal of Chemical Information and Modeling|March 29, 2011
Rationalizing the role of SAR tolerance for ligand-based virtual screeningPeter Ripphausen, Britta Nisius, Mathias Wawer, et al.
Journal of Medicinal Chemistry|October 9, 2010
Quo vadis, virtual screening? A comprehensive survey of prospective applicationsPeter Ripphausen, Britta Nisius, Lisa Peltason, et al.
Journal of Medicinal Chemistry|June 27, 2012
Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidasePeter Ripphausen, Marianne Freundlieb, Andreas Brunschweiger, et al.
Journal of Medicinal Chemistry|February 12, 2010
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffoldYounis Baqi, Sang-Yong Lee, Jamshed Iqbal, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|March 31, 2012
Virtual compound screening in drug discoveryDagmar Stumpfe, Peter Ripphausen, Jürgen Bajorath
Journal of Chemical Information and Modeling|September 10, 2011
REPROVIS-DB: a benchmark system for ligand-based virtual screening derived from reproducible prospective applicationsPeter Ripphausen, Anne Mai Wassermann, Jürgen Bajorath
Drug Discovery Today|February 26, 2011
State-of-the-art in ligand-based virtual screeningPeter Ripphausen, Britta Nisius, Jürgen Bajorath
Future Medicinal Chemistry|March 31, 2012
Analysis of structure-based virtual screening studies and characterization of identified active compoundsPeter Ripphausen, Dagmar Stumpfe, Jürgen Bajorath
Journal of Chemical Information and Modeling|March 29, 2011
Rationalizing the role of SAR tolerance for ligand-based virtual screeningPeter Ripphausen, Britta Nisius, Mathias Wawer, et al.
Journal of Medicinal Chemistry|October 9, 2010
Quo vadis, virtual screening? A comprehensive survey of prospective applicationsPeter Ripphausen, Britta Nisius, Lisa Peltason, et al.
Journal of Medicinal Chemistry|June 27, 2012
Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidasePeter Ripphausen, Marianne Freundlieb, Andreas Brunschweiger, et al.
Journal of Medicinal Chemistry|February 12, 2010
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffoldYounis Baqi, Sang-Yong Lee, Jamshed Iqbal, et al.
Pageof 1